By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

LSN announces the launch of the Focus on Cures Accelerator in Boston and will offer its first 2-week Immersion Course in the first quarter of 2019. The program is aimed at top life science companies from outside the US who are developing technologies in the four “Ds”—Drugs, Devices, Diagnostics and Digital Health—and are looking to connect with the global investor ecosystem as well as explore the leading Boston/Cambridge life science hub for future business development in the United States.

The program will be absolutely unique because of LSN’s deep resources:  investor and company data platforms that are unparalleled in the life sciences arena, the RESI conference series—laser-focused on early stage funding, Boston Innovation Capital investment banking experience and all of the contacts, connections and channel partners accumulated and curated over the years.

The FOC Accelerator 2-week Immersion Course will provide the following benefits:

Your office in Boston

Use of the LSN coworking space in Downtown Boston

Mentorship

• Tactical advice on how the cross-border global partnering arena works
• A thorough understanding of the ten categories of early stage investors and partners including family offices, foundations, endowments, angel investors, venture capitalists, private equity, strategic pharma, corporate venture, government and hedge funds.
• All program services, office space, class room are included in the fee. FOC Accelerator charges no success fees and takes no equity in any of the participating companies.

Networking

• Because LSN’s RESI conference is a global partnering ecosystem built upon the two life science databases LSN offers, we know a lot of the major players across the silos of drugs, devices, diagnostics and digital health.
• Increased visibility because you will be given a list of investors and partners that are a fit for your company and product. All of FOC Accelerator companies will have access to our worldwide network.
• FOC can provide hands on support for setting up your company’s U.S. operations.

Partnerships

• Finding the right partners that are a fit for your stage of development and product set is key to your success.
• LSN has helped more than 375 companies raise over 500 million dollars. LSN products and services are used by all the core players who use LSN to source technology assets.
• LSN can provide a rapid entry into our world’s leading life science ecosystem and a chance to find the right partners to move your firm to the next level in the life sciences market.

Click Here to View the Full Details of the FOC Accelerator

For more information please contact LSN at info@lifesciencenation.com

By Karen Deyo, Investor Research Analyst, LSN

This January will feature our 21^st RESI conference in San Francisco during JPM. The RESI conference series has been held in multiple cities across North America and has grown to be the conference of reference for early-stage funding, with many companies attending multiple conferences to help form connections with potential investors and strategic partners and many investors utilizing RESI as a good source of quality deal flow. LSN’s global network of companies and investors have been calling for RESI to expand outside of North America, and it is with great excitement that we announce RESI Europe, taking place on March 25^th in Vienna, Austria. We are looking forward to bringing a full day of partnering meetings, panels and workshops to the global stage.   Registration will open next week. For more information, please contact resi@lifesciencenation.com. We hope to see you in Vienna!

By Lucy Parkinson, VP of Investor Research, LSN

At LSN, we’re looking forward to a RESI San Francisco packed with meetings, content and new connections. Over a thousand attendees will join us for the event, and hundreds of investors are already registered to attend. In addition to the networking potential of RESI San Francisco, LSN has also created an agenda full of investor panels related to key technologies and sources of investment in the early stage life science arena. These panels aim to inform entrepreneurs on who’s out there writing checks, and how to get on their radar.

RESI San Francisco will feature an Asia Track in the afternoon, including a new panel on Asia Corporates & Strategics, and our first ever devoted panel on Taiwan Investors, led by BioMed Taiwan. The event also includes RESI’s first ever panel devoted to Investing in Cell & Gene Therapy, a West Coast Innovator’s Pitch Challenge, and the return of RESI’s popular sessions on Mental & Behavioural Health, Corporate Venture Capital, and Personalized Medicine. If you’d like to join us for this full day of content, register now!

By Karen Deyo, Investor Research Analyst, LSN

The Digital Health sector has been rapidly expanding, with applications ranging from consumer-facing technologies to physician tools for care coordination to AI-based diagnostics platforms. The nature of this sector, with the much shorter time-to-commercialization as well as the ease in entering the market has led to a great deal of investment in this space. However, this leads to some big differences in the strategies employed by investors, as well as unique challenges faced by fundraising CEOs in this space. In addition, companies and investors alike must take into account the shifting regulatory environment as the FDA grapples with a strategy to evaluate Digital Health technologies, either as standalone products or as part of combination devices.

At our upcoming RESI conference in San Francisco on January 8^th, we have five investors who focus on Digital Health who are willing to share their expertise about what’s hot, what not to do and how to face the challenges and avoid the pitfalls that are common in this sector. Make sure to make your way to the panel, taking place from 10:00-10:50 am!

The panelists speaking on the Digital Health panel are:

• Dennis Depenbusch, Director, New Ventures Initiative, BCBSKS New Ventures Initiative
• Brenda Irwin, Managing Partner & Co-Founder, Relentless Pursuit Partners
• Dominik Mayer, Principal, AO Invest
• Skip Fleshman, Partner, Asset Management Ventures
• Debbie Lin, Executive Director – Digital Health, Boehringer Ingelheim Venture Fund

By Nono Hu, Director of Marketing, LSN

We are counting down the days to the RESI NYC 2018 event on November 5th, and it’s now time for LSN to present the RESI NYC 2018 Program Guide. This RESI event draws upon both the rising biotech ecosystem in NY & NJ area and also LSN’s global network of investors and strategic movers in the life science space, and in the Program Guide, you can find speakers, sponsors, and innovators from all over the world. To check out the full RESI NYC 2018 content and lineup, view the Program Guide below.